Pancreatic cancer is one of the malignant tumors with the worst prognosis in humans. In the past three decades, although the overall five-year survival rate of pancreatic cancer has almost doubled, it is still only about 10%, making it the strongest fortress on the battlefield between humans and tumors. In this "battlefield", the world's top basic scientific researchers, epidemiologists, surgeons, oncologists, and experts and scholars from various fields such as imaging and pathology have gathered in their respective work for pancreatic cancer. Cancer patients fight for hope of survival and a cure.

Unfortunately, he suffered from an unresectable "cancer king". After going to many hospitals, he said that he had no chance of surgery and suggested conservative treatment... Recently, Mr. Wang's family came to the Jiangsu Provincial People's Hospital (Nanjing Medical University) while frowning. The Pancreatic Center of the First Affiliated Hospital), and the team of Professor Jiang Kuirong, director of the center, successfully performed a radical surgical resection for him, turning "impossible" into "possible". "I am very grateful to the doctors and nurses of the Pancreas Center of Jiangsu Provincial People's Hospital. The operation has given me hope again!" Mr. Wang, who was discharged from the hospital, said sincerely before leaving.

On February 16, 2022, "JAMA Network Open" published online the research results of the team of Professor Yi Miao and Professor Jiang Kuirong from the Pancreatic Center of the First Affiliated Hospital of Nanjing Medical University, "Prevalence of Germline Sequence Variations of Pancreatic Carcinoma in Chinese Population". Among Patients
With Pancreatic Cancer in China”), the study included more than 2,000 patients with pancreatic cancer and other pancreatic diseases, including 1,009 patients with pancreatic cancer, and systematically analyzed the occurrence of germline mutations in pancreatic diseases and pan-cancer susceptibility genes in the Chinese population.